Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
2
×
national top stories
abbvie
acorda therapeutics
ampyra
apokyn
apomorphine
biotech
boston blog main
boston top stories
cancer
cancer immunotherapy
checkpoint inhibitors
clinical trials
ctla-4
ctla-4 inhibitor
dalfampridine
duopa
inbrija
james allison
keytruda
mylan
national
new york
new york blog main
new york top stories
nobel
nobel prize
opdivo
parkinson's disease
paul matteis
pd-1
pd-1 inhibitor
san francisco blog main
san francisco top stories
stiel
sunovion pharmaceuticals
tasuku honjo
texas blog main
What
patients
2
×
treatment
2
×
acorda
allison
approved
cancer
cancers
cope
countless
disease
drug
episodes
fda
fight
friday
gets
harnessing
help
honjo
honors
immune
immunotherapy
late
lives
looms
meant
medications
medicine
new
nobel
nod
parkinson’s
pioneers
prize
rival
seen
stop
transformed
working
Language
Current search:
patients
×
treatment
×
" national blog main "
×
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison & Honjo
